Damarys García Gómez
Research Subjects
Damarys García Gómez has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Anduriña Barrios Martínez
Centro Nacional de Genética Medica. La Habana, Cuba
4 shared publications - Enny Morales Rodríguez
Centro Nacional de Genética Medica. La Habana, Cuba
4 shared publications - Luis Alberto Méndez Rosado
Centro Nacional de Genética Medica. La Habana, Cuba
4 shared publications - Arlay Castelvi López
Centro Nacional de Genética Médica de Cuba, La Habana, Cuba
3 shared publications - Michel Soriano-Torres
Centro Nacional de Genética Medica. La Habana, Cuba
3 shared publications - Alina García García
Hospital pediátrico universitario “William Soler”. Habana. Cuba
2 shared publications
Latest Publications
- Open Access
- 27 April 2026
- Published by Universidad Nacional Federico Villarreal in The Biologist
- Vol. 24 (1) , 35-40
Caracterización citogenética y molecular de cuatro pacientes con desarrollo sexual diferente
Las diferencias del desarrollo sexual, comprenden un espectro diverso de condiciones originadas por alteraciones en las etapas del desarrollo fetal relacionadas con el sexo genético, gonadal o fenotípico. Con una prevalencia inferior a 1 caso por cada 2 000 recién nacidos, estas entidades se clasifican como enfermedades raras. El objetivo fue caracterizar citogenéticamente y molecularmente a cuatro pacientes con desarrollo sexual diferente con el fin de establecer correlaciones genotipo-fenotipo. Fueron evaluados cuatro pacientes, debido a los trastornos reproductivos que presentaban. Se realizó cultivo de linfocitos con bandeo GTG, complementado con hibridación in situ fluorescente mediante sondas centroméricas del X y locus específico del gen SRY. También la detección del gen SRY se llevó a cabo mediante reacción en cadena de la polimerasa. Tres pacientes con fenotipo masculino presentaron cariotipo 46,XX y presencia del gen SRY, sugiriendo una translocación del locus SRY al cromosoma X durante la meiosis paterna. Un paciente con fenotipo femenino mostró un cariotipo 46,XY y ausencia del gen SRY. Se observan peculiaridades fenotípicas en los pacientes acordes con el diagnóstico realizado. La integración de técnicas citogenéticas (cariotipo + FISH) y moleculares (detección de SRY) es fundamental para el diagnóstico preciso de estas entidades. Estos hallazgos no solo permiten elucidar mecanismos genéticos subyacentes, sino que también orientan estrategias de asesoramiento genético personalizadas, minimizando la incertidumbre clínica en las familias afectadas.
- 27 April 2026
- Published by Universidad Nacional Federico Villarreal in The Biologist
- Vol. 24 (1) , 35-40
Open AccessCaracterización citogenética y molecular de cuatro pacientes con desarrollo sexual diferente
Las diferencias del desarrollo sexual, comprenden un espectro diverso de condiciones originadas por alteraciones en las etapas del desarrollo fetal relacionadas con el sexo genético, gonadal o fenotípico. Con una prevalencia inferior a 1 caso por cada 2 000 recién nacidos, estas entidades se clasifican como enfermedades raras. El objetivo fue caracterizar citogenéticamente y molecularmente a cuatro pacientes con desarrollo sexual diferente con el fin de establecer correlaciones genotipo-fenotipo. Fueron evaluados cuatro pacientes, debido a los trastornos reproductivos que presentaban. Se realizó cultivo de linfocitos con bandeo GTG, complementado con hibridación in situ fluorescente mediante sondas centroméricas del X y locus específico del gen SRY. También la detección del gen SRY se llevó a cabo mediante reacción en cadena de la polimerasa. Tres pacientes con fenotipo masculino presentaron cariotipo 46,XX y presencia del gen SRY, sugiriendo una translocación del locus SRY al cromosoma X durante la meiosis paterna. Un paciente con fenotipo femenino mostró un cariotipo 46,XY y ausencia del gen SRY. Se observan peculiaridades fenotípicas en los pacientes acordes con el diagnóstico realizado. La integración de técnicas citogenéticas (cariotipo + FISH) y moleculares (detección de SRY) es fundamental para el diagnóstico preciso de estas entidades. Estos hallazgos no solo permiten elucidar mecanismos genéticos subyacentes, sino que también orientan estrategias de asesoramiento genético personalizadas, minimizando la incertidumbre clínica en las familias afectadas.
- Open Access
- 20 June 2025
- Published by South American Publishing in South Health and Policy
- Vol. 4, 166
Training competencies in dysmorphology: learning needs for professionals involved in clinical genetics
Introduction: Recent advances in molecular genetics and the use of artificial intelligence require professionals whose work is related to clinical genetics to have a basic knowledge of dysmorphology. It is therefore necessary to design a teaching strategy to improve their professional performance. Objective: To identify learning needs in dysmorphology for professions related to clinical genetics.Methods: A descriptive cross-sectional observational study was conducted on a non-probabilistic accidental sample of 80 professionals who attended the face-to-face conference “Dysmorphology: current challenges” and who were willing to respond to an anonymous printed questionnaire. Descriptive statistical methods were used to process the data. Results: The average age of those who responded to the questionnaire was 46.83, the majority were female (92.5%), predominantly doctors (48.75%), with an average of 23 years of professional experience. Fifty-one point twenty-five percent were in teaching positions and fifty-two point five percent were scientists. Most attendees were satisfied with the conference, and the majority of proposals for postgraduate activities to be carried out during the course (sixty-three point three percent) included the use of technology for diagnosis (one hundred percent) and the use of nomenclature in dysmorphology (ninety-five point five percent). Conclusion: The handling of nomenclature in semiology and the application of technology for diagnosis were identified as learning needs.
- 20 June 2025
- Published by South American Publishing in South Health and Policy
- Vol. 4, 166
Open AccessTraining competencies in dysmorphology: learning needs for professionals involved in clinical genetics
Introduction: Recent advances in molecular genetics and the use of artificial intelligence require professionals whose work is related to clinical genetics to have a basic knowledge of dysmorphology. It is therefore necessary to design a teaching strategy to improve their professional performance. Objective: To identify learning needs in dysmorphology for professions related to clinical genetics.Methods: A descriptive cross-sectional observational study was conducted on a non-probabilistic accidental sample of 80 professionals who attended the face-to-face conference “Dysmorphology: current challenges” and who were willing to respond to an anonymous printed questionnaire. Descriptive statistical methods were used to process the data. Results: The average age of those who responded to the questionnaire was 46.83, the majority were female (92.5%), predominantly doctors (48.75%), with an average of 23 years of professional experience. Fifty-one point twenty-five percent were in teaching positions and fifty-two point five percent were scientists. Most attendees were satisfied with the conference, and the majority of proposals for postgraduate activities to be carried out during the course (sixty-three point three percent) included the use of technology for diagnosis (one hundred percent) and the use of nomenclature in dysmorphology (ninety-five point five percent). Conclusion: The handling of nomenclature in semiology and the application of technology for diagnosis were identified as learning needs.
- Open Access
- 31 December 2024
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 3, .344
Cytogenetic diagnosis of Pallister Killian syndrome
Introduction: Pallister-Killian syndrome (PKS) is a rare multiple congenital anomaly/intellectual disability syndrome caused by tissue-restricted, mosaic tetrasomy 12p. The most common signs are facial dysmorphism, rhizomelic shortening of the extremities, pigmentary mosaic in skin; craniofacial manifestations include a ''coarse'' face with a flat profile and a wide forehead with sparse scalp hair in temporofrontal regions.Objective: To describe the karyotype and clinical manifestations in patients with suspected Pallister Killian Syndrome.Methods: Chromosomal studies were performed using conventional techniques in peripheral blood samples and skin samples in two patients, and a sample of amniotic fluid from a 17.3-week pregnant woman due to positive markers in the ultrasound. Peripheral blood cultures showed normal karyotypes in patients 1 and 2. Results: The fibroblast culture karyotypes of the patients studied reflected: Case 1: 47, XY+ i (12p) [8]/46 XY [10], Case 2:47, XY+ i (12p) (p10) [11] y Case 3: 47, XX + i (12p) [7]/46, XX [5] respectively. Conclusions:The SPK detected by conventional cytogenetics allowed a conclusive diagnosis in skin samples, despite the lack of molecular cytogenetic techniques, in those cases where chromosomal aberrations are restricted to a certain group of cells.
- 31 December 2024
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 3, .344
Open AccessCytogenetic diagnosis of Pallister Killian syndrome
Introduction: Pallister-Killian syndrome (PKS) is a rare multiple congenital anomaly/intellectual disability syndrome caused by tissue-restricted, mosaic tetrasomy 12p. The most common signs are facial dysmorphism, rhizomelic shortening of the extremities, pigmentary mosaic in skin; craniofacial manifestations include a ''coarse'' face with a flat profile and a wide forehead with sparse scalp hair in temporofrontal regions.Objective: To describe the karyotype and clinical manifestations in patients with suspected Pallister Killian Syndrome.Methods: Chromosomal studies were performed using conventional techniques in peripheral blood samples and skin samples in two patients, and a sample of amniotic fluid from a 17.3-week pregnant woman due to positive markers in the ultrasound. Peripheral blood cultures showed normal karyotypes in patients 1 and 2. Results: The fibroblast culture karyotypes of the patients studied reflected: Case 1: 47, XY+ i (12p) [8]/46 XY [10], Case 2:47, XY+ i (12p) (p10) [11] y Case 3: 47, XX + i (12p) [7]/46, XX [5] respectively. Conclusions:The SPK detected by conventional cytogenetics allowed a conclusive diagnosis in skin samples, despite the lack of molecular cytogenetic techniques, in those cases where chromosomal aberrations are restricted to a certain group of cells.
- Open Access
- 16 October 2024
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología - Serie de Conferencias
- Vol. 3, .697
Mosaic aneuploidy in a patient with periocular basal cell carcinoma. Report of a case
Basal cell carcinoma constitutes approximately 80% of non-melanocytic skin tumors and originates in the basal layer of the epidermis and its appendages. Genetic alterations that affect neoplastic development have been identified, caused by external physical or chemical agents, hereditary, chromosomal rearrangements, allelic loss and gene amplification. This article presents a white-skinned male individual, 64 years old, with a diagnosis of periocular basal cell carcinoma, who underwent a cytogenetic study of the tumor tissue and a mosaic chromosomal aneuploidy was identified.The presence of mosaic aneuploidy in patients with periocular basal cell carcinoma suggests that chromosomal aberrations may play an important role in tumor progression and aggressiveness. This finding highlights the need to integrate cytogenetic studies in the clinical evaluation of skin tumors, facilitating a better understanding of the underlying biological mechanisms, opening new avenues for therapeutic research.
- 16 October 2024
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología - Serie de Conferencias
- Vol. 3, .697
Open AccessMosaic aneuploidy in a patient with periocular basal cell carcinoma. Report of a case
Basal cell carcinoma constitutes approximately 80% of non-melanocytic skin tumors and originates in the basal layer of the epidermis and its appendages. Genetic alterations that affect neoplastic development have been identified, caused by external physical or chemical agents, hereditary, chromosomal rearrangements, allelic loss and gene amplification. This article presents a white-skinned male individual, 64 years old, with a diagnosis of periocular basal cell carcinoma, who underwent a cytogenetic study of the tumor tissue and a mosaic chromosomal aneuploidy was identified.The presence of mosaic aneuploidy in patients with periocular basal cell carcinoma suggests that chromosomal aberrations may play an important role in tumor progression and aggressiveness. This finding highlights the need to integrate cytogenetic studies in the clinical evaluation of skin tumors, facilitating a better understanding of the underlying biological mechanisms, opening new avenues for therapeutic research.
- Open Access
- 8 May 2023
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología - Serie de Conferencias
- Vol. 2, 250
Chromosomal aberrations in patients with suspected Prader Willi syndrome
Introduction: Prader-Willi syndrome, caused by the absence of expression of the paternal 15q11-13 region, is the first imprinting defect disorder described in humans. With an incidence of 1 in 10000-15000, its clinical phenotype characterized by hypotonia, obesity and hypogonadism overlaps with a group of genetically heterogeneous syndromes defined as Prader Willi-like syndrome or Prader Willi like. In this group, deletion 1p36, deletion 2p, deletion 6q, among others, are reported. Objective: to identify chromosomal aberrations in the conventional karyotype of patients with suspected Prader Willi syndrome. Methods: we analyzed the results of conventional karyotyping in lymphocytes, FISH molecular studies and methylation-based polymerase chain reaction of 112 patients referred during the period 2010-2019 for suspected Prader Willi syndrome. Results: Prader Willi syndrome was confirmed in 45,5 % of the patients. Chromosomal aberrations outside the 15q11.13 region were found in 5,3 % of cases including: chromosome 22 ring, trisomy 21 mosaic, 6p admixture, reverse sex and chromosome 21 inversion. Conclusions: In patients with Prader Willi phenotype, clinical suspicion is often not confirmed by molecular studies. Conventional karyotyping may reveal Prader Willi-like syndrome due to aberrations at sites involved in neuroendocrine control outside the 15q11.13 region. In these cases chromosomal diagnosis is essential for more effective prevention strategies as part of genetic counseling for patients and families.
- 8 May 2023
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología - Serie de Conferencias
- Vol. 2, 250
Open AccessChromosomal aberrations in patients with suspected Prader Willi syndrome
Introduction: Prader-Willi syndrome, caused by the absence of expression of the paternal 15q11-13 region, is the first imprinting defect disorder described in humans. With an incidence of 1 in 10000-15000, its clinical phenotype characterized by hypotonia, obesity and hypogonadism overlaps with a group of genetically heterogeneous syndromes defined as Prader Willi-like syndrome or Prader Willi like. In this group, deletion 1p36, deletion 2p, deletion 6q, among others, are reported. Objective: to identify chromosomal aberrations in the conventional karyotype of patients with suspected Prader Willi syndrome. Methods: we analyzed the results of conventional karyotyping in lymphocytes, FISH molecular studies and methylation-based polymerase chain reaction of 112 patients referred during the period 2010-2019 for suspected Prader Willi syndrome. Results: Prader Willi syndrome was confirmed in 45,5 % of the patients. Chromosomal aberrations outside the 15q11.13 region were found in 5,3 % of cases including: chromosome 22 ring, trisomy 21 mosaic, 6p admixture, reverse sex and chromosome 21 inversion. Conclusions: In patients with Prader Willi phenotype, clinical suspicion is often not confirmed by molecular studies. Conventional karyotyping may reveal Prader Willi-like syndrome due to aberrations at sites involved in neuroendocrine control outside the 15q11.13 region. In these cases chromosomal diagnosis is essential for more effective prevention strategies as part of genetic counseling for patients and families.
- Open Access
- 8 May 2023
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología - Serie de Conferencias
- Vol. 2 (3) , 340
Rearreglos cromosómicos complejos involucrados en la infertilidad masculina
Los rearreglos cromosómicos complejos (RCC) constituyen aberraciones que involucran tres o más cromosomas o tres o más puntos de rupturas, son extremadamente raros y aproximadamente más de la mitad están asociados a fenotipos afectados. Generalmente el diagnóstico se realiza aplicando métodos como el cariotipo molecular (aCGH) e hibridación in situ por fluorescencia (FISH). Para el análisis citogenético se utilizó cultivo de linfocitos en sangre periférica estimulados con fitohemaglutinina usando los métodos de citogenética convencional y adaptados a las condiciones del Laboratorio de Citogenética del Centro Nacional de Genética Médica. Fueron analizadas 15 metafases por pacientes con una resolución de 450 bandas por set haploide. Se empleó el método de clasificación de las RCC creado por Kausch y colaboradores. Los pacientes estudiados, provenían de la consulta de Reproducción Asistida del Hospital Ramón González Coro donde, acudieron por presentar trastornos reproductivos. Fueron evaluados en consulta interdisciplinaria y se remitieron al laboratorio de citogenética para el análisis de su complemento cromosómico. En el análisis y asesoramiento genético de estos tres pacientes portadores de RCC se deben tomar en consideración todos los aspectos anteriormente mencionados, con la evidente limitación en nuestro medio de no disponer de pruebas moleculares para la detección de algún tipo de reordenamiento críptico o alguna mutación puntual en determinado gen. No obstante, con la utilización de los métodos de la citogenética convencional se puede establecer en cada portador de RCC un asesoramiento genético personalizado teniendo en cuenta los cromosomas implicados, el punto de ruptura, el tamaño del segmento translocado y los posibles genes implicados en el punto de ruptura.
- 8 May 2023
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología - Serie de Conferencias
- Vol. 2 (3) , 340
Open AccessRearreglos cromosómicos complejos involucrados en la infertilidad masculina
Los rearreglos cromosómicos complejos (RCC) constituyen aberraciones que involucran tres o más cromosomas o tres o más puntos de rupturas, son extremadamente raros y aproximadamente más de la mitad están asociados a fenotipos afectados. Generalmente el diagnóstico se realiza aplicando métodos como el cariotipo molecular (aCGH) e hibridación in situ por fluorescencia (FISH). Para el análisis citogenético se utilizó cultivo de linfocitos en sangre periférica estimulados con fitohemaglutinina usando los métodos de citogenética convencional y adaptados a las condiciones del Laboratorio de Citogenética del Centro Nacional de Genética Médica. Fueron analizadas 15 metafases por pacientes con una resolución de 450 bandas por set haploide. Se empleó el método de clasificación de las RCC creado por Kausch y colaboradores. Los pacientes estudiados, provenían de la consulta de Reproducción Asistida del Hospital Ramón González Coro donde, acudieron por presentar trastornos reproductivos. Fueron evaluados en consulta interdisciplinaria y se remitieron al laboratorio de citogenética para el análisis de su complemento cromosómico. En el análisis y asesoramiento genético de estos tres pacientes portadores de RCC se deben tomar en consideración todos los aspectos anteriormente mencionados, con la evidente limitación en nuestro medio de no disponer de pruebas moleculares para la detección de algún tipo de reordenamiento críptico o alguna mutación puntual en determinado gen. No obstante, con la utilización de los métodos de la citogenética convencional se puede establecer en cada portador de RCC un asesoramiento genético personalizado teniendo en cuenta los cromosomas implicados, el punto de ruptura, el tamaño del segmento translocado y los posibles genes implicados en el punto de ruptura.